These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2416481)

  • 21. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
    Jolivet J; Cole DE; Holcenberg JS; Poplack DG
    Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
    Dolezalová P; Krijt J; Chládek J; Nemcová D; Hoza J
    Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug.
    Pizzorno G; Chang YM; McGuire JJ; Bertino JR
    Cancer Res; 1989 Oct; 49(19):5275-80. PubMed ID: 2475246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of methotrexate and dihydrofolate polyglutamates in the enhancement of fluorouracil action by methotrexate.
    Fernandes DJ; Moroson BA; Bertino JR
    Cancer Treat Rep; 1981; 65 Suppl 1():29-35. PubMed ID: 6173121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate.
    Schalhorn A; Sauer H; Wilmanns W; Stupp-Poutot G
    Cancer Chemother Pharmacol; 1982; 9(1):65-9. PubMed ID: 7139854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for negative feedback of extracellular methotrexate on blasts of acute lymphoblastic leukemia in vitro.
    Hum MC; Smith AK; Lark RH; Winick NJ; Kamen BA
    Pharmacotherapy; 1997; 17(6):1260-6. PubMed ID: 9399609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates.
    Cowan KH; Jolivet J
    J Biol Chem; 1984 Sep; 259(17):10793-800. PubMed ID: 6206061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of folinic acid on hepatoma cells containing methotrexate polyglutamates.
    Galivan J; Nimec Z
    Cancer Res; 1983 Feb; 43(2):551-5. PubMed ID: 6184149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of the intracellular levels of polyglutamyl derivatives of methotrexate by vincristine and probenecid in Ehrlich ascites tumor cells.
    Fry DW; Yalowich JC; Goldman ID
    Cancer Res; 1982 Jul; 42(7):2532-6. PubMed ID: 6177396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.
    Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID
    Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate.
    Li WW; Tong WP; Bertino JR
    Clin Cancer Res; 1995 Jun; 1(6):631-6. PubMed ID: 9816025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferation-dependent cytotoxicity of methotrexate in murine L5178Y leukemia.
    Fernandes DJ; Sur P; Kute TE; Capizzi RL
    Cancer Res; 1988 Oct; 48(20):5638-44. PubMed ID: 2458828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells.
    Jolivet J; Schilsky RL; Bailey BD; Drake JC; Chabner BA
    J Clin Invest; 1982 Aug; 70(2):351-60. PubMed ID: 6178756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro.
    Fabre G; Goldman ID
    Cancer Res; 1985 Jan; 45(1):80-5. PubMed ID: 2578101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia.
    Schrøder H; Fogh K
    Cancer Chemother Pharmacol; 1988; 21(2):145-9. PubMed ID: 2450690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ.
    Krakower GR; Kamen BA
    J Pharmacol Exp Ther; 1984 Oct; 231(1):43-7. PubMed ID: 6208355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro approach to 7-hydroxymethotrexate interaction on methotrexate metabolism as tool of pharmacokinetic study.
    Fabre G; Cano JP; Catalin J; Just S
    Int J Clin Pharmacol Res; 1983; 3(6):475-84. PubMed ID: 6590470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.
    Pizzorno G; Mini E; Coronnello M; McGuire JJ; Moroson BA; Cashmore AR; Dreyer RN; Lin JT; Mazzei T; Periti P
    Cancer Res; 1988 Apr; 48(8):2149-55. PubMed ID: 2450647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. Definition of a two-step process limited by mediated lysosomal permeation of polyglutamates and activating reduced sulfhydryl compounds.
    Barrueco JR; O'Leary DF; Sirotnak FM
    J Biol Chem; 1992 Aug; 267(22):15356-61. PubMed ID: 1379226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.